Editorial: Novel theranostic agents for precision therapeutics

Shahid Karim; Nasir Ali Siddiqui; Mohammad Imran Khan; Muhammad Wahajuddin; Shariq Syed

PMC · DOI:10.3389/fphar.2024.1407366·April 17, 2024

Editorial: Novel theranostic agents for precision therapeutics

Shahid Karim, Nasir Ali Siddiqui, Mohammad Imran Khan, Muhammad Wahajuddin, Shariq Syed

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Genes7

AKT1 TNF MTOR FOLH1 PIK3CG CYP19A1 EGFR

Proteins7

Species2

Homo sapiens(human · species)Gymnema sylvestre(species)

Chemicals13

GCG EGCG flavonoids mangiferin ATP Gallated catechins gentamicin catechin curcumin neo-tanshinlactone 68Ga chalcone Gymnemic acid

Diseases6

MCF-7 cancer prostate cancer Ovarian cancer acute renal damage breast cancer cancer

Mutations1

L858R

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsNanoparticle-Based Drug Delivery · Advanced biosensing and bioanalysis techniques · Nanoplatforms for cancer theranostics